LB Pharmaceuticals Statistics
NASDAQ: LBRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
34.61+0.45 (+1.32%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 34.61 0.00%
LB Pharmaceuticals by the numbers
LB Pharmaceuticals has a market capitalization of $1.12 billion based on 32.26M shares outstanding. Its trailing P/E ratio is 346.1. The stock trades 21.0% below its 50-day average and 11.2% above its 200-day average.
Average daily trading volume is 341.17K shares, or about $11.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LBRX valuation vs. peer median
| Metric | LBRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.12B | $1.14B | -2% |
| Avg. volume | 341.17K | 582.80K | -41% |
Peer median across 8 companies: MNKD, AMPH, JANX, AVLN, BCAX, TRAX, HROW, NBTX.
Valuation
- Market cap
- $1.12B
- P/E (TTM)
- 346.10
- EPS (TTM)
- $0.10
- Shares outstanding
- 32.26M
Price and trading
- Previous close
- 34.16
- Open
- 33.83
- Day range
- 33.13 – 35.73
- 52-week range
- 14.32 – 50.16
- 52-week change
- +113.37%
- Beta
- —
- Volume
- 440.65K
- Average volume
- 341.17K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 1.12B
- Pe
- 346.10
- Forward Pe
- -6.69
- Eps
- 0.10
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 50.16
- Week52 Low
- 14.32
- Avg Volume
- 341.17K
- Shares Outstanding
- 32.26M
- Ma50
- 43.84
- Ma200
- 31.13
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -31.00%
- Pct From52w Low
- 141.74%